(Q42675109)
Statements
1 reference
Long-term therapy with the dual 5alpha-reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasia (English)
1 reference
Claude Schulman
1 reference
Peter Pommerville
1 reference
Klaus Höfner
1 reference
Barton Wachs
1 reference
1 January 2006
1 reference
1 reference
97
1 reference
1
1 reference
73-9; discussion 79-80
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference